ARTIVA BIOTHERAPEUTICS - REPORTS PRELIMINARY CASH, CASH EQUIVALENTS AND INVESTMENTS OF $319.10 MLN AS OF SEPT 30, 2026

Reuters · 4d ago

Please log in to view news